Reversion of deregulated expression of vascular endothelial growth factor in human renal carcinoma cells by von Hippel-Lindau tumor suppressor protein

Cancer Research

Volumn 56, Issue 10, 1996, Pages 2299-2301

  Siemeister, Gerhard ^a   Weindel, Karin ^a   Mohrs, Katja ^a   Barleon, Bernhard ^a   Martiny Baron, Georg ^a   Marmé, Dieter ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P21; VASCULOTROPIN;

ARTICLE; CELL PROLIFERATION; GENE MUTATION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN SYNTHESIS REGULATION; PROTO ONCOGENE; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; TUMOR VASCULARIZATION; VON HIPPEL LINDAU DISEASE;

CARCINOMA, RENAL CELL; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MYC; GENES, TUMOR SUPPRESSOR; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; LIGASES; LYMPHOKINES; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PHENOTYPE; PROTEIN BIOSYNTHESIS; PROTEINS; RECOMBINANT FUSION PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN;

EID: 0029920054     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Latif, F., Tory, K., Gnarra, J., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science (Washington DC), 260. 1317-1320, 1993.
2. Gnarra, J R , Tory, K , Weng, Y., et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nat. Genet., 7: 85-90, 1994.
3. Duan, D. R , Pause, A., Burgess, W. H., Aso, T., Chen, D. Y. T., Garrett, K. P., Conaway, R. C., Conaway, J W., Linehan, W. M., and Klausner, R. D. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science (Washington DC), 269: 1402-1406, 1995.
4. Aso, T., Lane, W. S., Conaway, J. W., and Conaway, R. C. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II Science (Washington DC), 269: 1439-1443, 1995
5. Kibel, A , Iliopoulos, O., DeCaprio, J. A., and Kaelin, W. G., Jr. Binding of the von Hippel-Lindau tumor suppressor protein to elongin B and C Science (Washington DC), 269: 1444-1446, 1995.
6. Krumm, A , and Groudine, M. Tumor suppression and transcription elongation: the dire consequences of changing partners. Science (Washington DC), 269. 1400-1401, 1995.
7. Martiny-Baron, G., and Marmé, D. VEGF-mediated tumour angiogenesis, a new target for cancer therapy. Curr. Opin Biotechnol , 6: 675-680, 1995.
8. Tischer, E , Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D , Fiddes, J. C , and Abraham, J A. The human gene for vascular endothelial growth factor. J. Biol. Chem., 266. 11947-11954, 1991
9. Grugel, S., Finkenzeller, G., Weindel, K., Barleon, B., and Marmé, D Both v-Ha-Ras and v-Raf stimulate expression of the vascular endothelial growth factor in NIH 3T3 cells J Biol. Chem , 270 25915-25919, 1995.
10. Rak, J., Mitsuhashi, Y., Bayko, L , Filmus, J , Shirasawa, S., Sasazuki, T., and Kerbel, R. S. Mutant ras oncogenes up-regulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res , 55. 4575-4580, 1995.
11. Finkenzeller, G., Technau, A , and Marmé, D. Hypoxia-induced transcription of the vascular endothelial growth factor gene is independent of functional AP-1 transcription factor. Biochem Biophys. Res. Commun., 208: 432-439, 1995.
12. Shweiki, D , Itin, A., Soffer, D , and Keshet, E Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature (Lond.), 359 843-845, 1992.
13. Ikeda, E , Achen, M G., Breier, G , and Risau, W. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells. J. Biol Chem , 270 19761-19766, 1995.
14. Iliopoulos, O., Kibel, A., Gray, S , and Kaelin, W. G., Jr. Tumour suppression by the human von Hippel-Lindau gene product Nat. Med , 1: 822-826, 1995.
15. Sambrook, J., Fritsch, E F , and Maniatis, T. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor, NY Cold Spring Harbor Laboratory, 1989.
16. Eick, D , Kohlhuber, F., Wolf, D. A., and Strobl, L J Activation of pausing RNA polymerase by nuclear run-on experiments. Anal. Biochem., 218. 347-351, 1994.
17. Krumm, A., Hickey, L. B., and Groudine, M. Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes & Dev , 9: 559-572, 1995
18. Wizigmann-Voos, S., Breier, G., Risau, W , and Plate, K. H. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas Cancer Res., 55 1358-1364, 1995